In our research, we comprehensively investigated the expression, prognosis, functional enrichment of KIF2C in PCa, and the association between KIF2C expression and DNA methylation, clinical characteristics, immune response, and drug resistance. This evidence concerns the gene KIF2C and posterior cortical atrophy.